Early diagnosis of cardiac decompensation is essential to improve therapy of heart failure as one of the most costintensive chronic diseases worldwide. This can be achieved by remote monitoring of pulmonary artery pressure. An implantable pressure sensor system is developed in a joint research project (COMPASS), funded by the BMBF. The application of pulse contour analysis, which is well established for stroke volume estimation based on aortic blood pressure, to pulmonary artery pressure (PAP) is challenging due to different signal morphology and limited signal resolution. Especially the incisure in the pressure signal which marks valve closure is often not visible. Therefore, it was investigated whether valve closure can be detected by additional use of heart sounds more reliably. Blood pressure of an anesthetized Rhoen sheep was measured in the pulmonary artery with the implantable pressure monitor COMPASS and, for reference, additionally with commercial pressure catheters (Millar Instruments) in the pulmonary artery, aorta, left and right ventricles. Heart sounds were detected with a 3D accelerometer fixed at the animal's chest. For reference, valve opening and closure were derived from left ventricular pressure. With PAP only, 6.3% of all cardiac cycles were unusable for PCA at low and medium heart rates, as either valve opening or closure were missed or not correctly identified. At very high heart rates the loss rate increased up to 87%. When both PAP and accelerometer data were used, the loss rate was reduced to 0.1% … 0.4% for all heart rates. Combining blood pressure analysis with heart sounds improves the detection of valve opening and closure and thus SV estimation, especially at high heart rates.
Introduction
Heart failure has not only a dramatic impact on the affected patients, but also on the national health care systems. Since 2006 heart failure is the most frequent reason for hospitalisation, and is, moreover, one of the most costintensive chronic diseases, being responsible for about 1% to 2% of healthcare costs in industrialised countries. The largest part of the costs results from the hospitalisation; a fact that strongly drives the research for early detection methods of cardiac decompensation that precedes a hospitalisation by telemonitoring. It was already shown that the pulmonary artery pressure is a valuable parameter for the management of heart failure patients [1] . In this study, an implantable pulmonary artery pressure monitor being currently under development is evaluated in an in-vivo test. Moreover, it is investigated whether the application of pulse contour analysis for stroke volume estimation might be improved by additional detection of heart sounds with an accelerometer sensor.
Methods

Implantable pressure monitoring system (COMPASS)
In a national research project "COMPASS" funded by the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF), an implantable pressure sensing system is being developed for remote monitoring of the pulmonary artery pressure [2] . It consists of a miniaturized implantable pressure sensing probe to be implanted in the pulmonary artery, a subcutaneous RF implant which contains sensor readout and RF telemetry electronics as well as the battery, and an external patient device for remote data transmission ( Figure 1 ). The pressure sensing probe contains a sensor chip with 40 pressuresensitive capacitive elements and a signal processing chip for immediate further processing of the small changes in capacitance [2] . Currently, prototypes of the sensor system are being evaluated in preclinical tests.
Figure 1:
COMPASS pressure monitoring system, consisting of a pressure sensor (1) implanted in the pulmonary artery, which is connected to a subcutaneous implant (2) with a sensor cable, and an external patient device (3).
Experimental Setup
The pressure sensor probe was implanted in an acute setting in an anesthetized Rhoen sheep using a specially developed minimally invasive implantation technique [3] . For reference, two 2-channel pressure transducer catheters (SP 780C, Millar Instruments, Houston, Texas) were introduced for simultaneous continuous measurement of left ventricular pressure (LVP), aortic pressure (AoP), right ventricular pressure (RVP) and pulmonary artery pressure (PAP). Furthermore, a stimulation catheter was placed in the right atrium for external stimulation. Additionally, heart sounds were recorded with an external accelerometer probe that was fixed at the chest wall of the sheep. It contained a 3-axis accelerometer CMA3000-A01 (VTI Technologies Oy, Vantaa, Finland). Heart sounds (3-channel), Millar pressure signals and the COMPASS pressure signal were recorded simultaneously during a baseline phase (normal sinus rhythm at approx. 75 bpm), an overstimulation test and a Dobutamine test to simulate different hemodynamic conditions.
Data Analysis
For each condition, phases of stable hemodynamics were identified and used for further analysis. Millar and heart sound signals were recorded with a resolution of 16 bit at a sample rate of 4 kHz using PowerLab (ADInstruments, Sidney, Australia). COMPASS pressure data was recorded using a customized readout unit at 64 and 128 Hz, respectively. Pulse Contour Analysis (PCA) is an established method to estimate stroke volume by integrating aortic or pulmonary blood pressure during systole:
While it has already been shown that PCA is, in general, applicable also for PAP [4] , signal processing is more difficult than for aortic pressure due to the impact of thoracic pressure variations from respiration on the PAP signal, and the smaller incisure indicating the end of systole. It is proposed in Fehler! Verweisquelle konnte nicht gefunden werden. to determine the end of systole by use of the second heart sound S 2 instead the PAP incisure to circumvent this problem (see Fehler! Verweisquelle konnte nicht gefunden werden. for detailed signal processing algorithms). Therefore, it was investigated in this analysis whether the detection of end of systole could be improved by additional use of S 2 over PAP alone. Figure 2 shows example plots of the PAP (Millar catheter) and accelerometer signals. The first and second heart sounds S 1 and S 2 are clearly detectable in the accelerometer signal. S 2 coincides with the PAP incisure and is a suitable parameter to indicate the end of systole if the incisure is hard or even not detectable. A direct comparison of the PAP signals measured by the COMPASS monitoring system and Millar catheter is shown in Figure 3 during baseline condition. While both signals are in good accordance quantitatively as well as regarding signal morphology, it is also obvious that small signal features and high-frequency spectral components of the signal are attenuated or even disappear in the COM-PASS signal due to the low sampling frequency (64 Hz in this recording), which will exacerbate a reliable incisure detection. This difficulty becomes even more evident as heart rate increases, as is shown in Figure 4 : the intrinsic heart rate increased to 180 bpm in consequence to the dobutamine infusion, and the incisure disappeared nearly completely in the COMPASS PAP signal. At the same time, S 2 could still be detected in the majority of cycles. The signal processing algorithms applied for analysis have been published in [5] . The number of heart cycles in which no incisure or S 2 could be detected is given in Table 1 : Percentage of heart cycles in which no incisure (PAP) or S 2 could be detected.
Results
While the failure rate in detecting the end of systole by use of incisure in PAP is 6.3% for baseline and overpacing conditions, it is reduced to 0.3% and 0.4%, respectively, by detection of S 2 . Moreover, in phases of very high heart rates such as during the Dobutamine test, the detection failure rate in PAP only of 87% is far too high for a reasonable application, while it remains very low (0.1%) when using S 2 .
Conclusion
The experimental data obtained so far from acute in-vivo tests show that PAP measurements performed with the COMPASS monitoring system are in good accordance with reference data from Millar catheters. The COMPASS signal seems to be suited for quantitative analysis (e.g., average diastolic, systolic and mean pressures) and pulse contour analysis for low and moderate heart rate with failure rates (lost cycles) of about 6%. For very high heart rates, PCA is not feasible since the incisure is no longer visible in the signal in the majority of cycles. By use of an additional accelerometer sensor, the second heart sound S 2 is detectable both at low and high heart rates with a very low failure rate between 0.1% and 0.4%. Therefore, an additional accelerometer sensor has the potential to improve the results of stroke volume estimation by pulse contour analysis significantly. Furthermore, it is desirable to use a higher sampling frequency than 64 Hz to maintain more spectral components of the measured pressure signal for further analysis.
